Biohaven Intranasal Migraine Drug Gets FDA Approval + Moderna’s mRNA Influenza Vaccine – Xtalks Life Science Podcast Ep. 41
XTalks
DECEMBER 15, 2021
Ayesha discusses the FDA approval of Biohaven’s intranasal spray Zavegepant for the acute treatment of migraines. The team also talked about results from an early-stage trial evaluating Moderna’s new mRNA-based influenza vaccine in adults. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Let's personalize your content